Science Explorer Interactive view Map
Company · Austin · United States

Mirna Therapeutics (United States)

Research works
66
▼ 64% vs 2013–17
Citations
6.5k
99.3 per fractional work
Top-10% rate
21.1%
record average 16.5%
Open access
52%
world 28%

Not ranked overall: Mirna Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.40× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.20× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 5.27× its world share, 1 worksImmunology and Micro…Neuroscience: 2.75× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 20.26× its world share, 1 worksPharmacology, Toxico…Chemistry: 1.30× its world share, 0 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.43× its world share, 0 worksEarth and Planetary …Engineering: 0.05× its world share, 0 worksEngineeringEnvironmental Science: 0.46× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.17× its world share, 1 worksMaterials ScienceHealth Professions: 0.71× its world share, 0 worksHealth ProfessionsMedicine: 2.17× its world share, 7 worksMedicineArts and Humanities: 0.71× its world share, 0 worksArts and HumanitiesSocial Sciences: 0.24× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 20.3×. Every wedge is a field page.

Who are the top researchers at Mirna Therapeutics (United States)?

Ranked on the composite score, Andreas G. Bader lead among researchers whose main affiliation is Mirna Therapeutics (United States).

  1. 1 Andreas G. Bader United States · #262,275 worldwide 203 citations · 24 works
All ranked researchers at Mirna Therapeutics (United States)

Which keywords describe research at Mirna Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Biogenesis, Regulation, Biomarkers, Gene Expression, Metastasis, Therapeutics and MicroRNA.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer16▲ 17×13 topics
  2. Biogenesis15▲ 204×3 topics
  3. Regulation15▲ 36×4 topics
  4. Biomarkers13▲ 31×4 topics
  5. Gene Expression12▲ 31×4 topics
  6. Metastasis12▲ 56×5 topics
  7. Therapeutics12▲ 125×2 topics
  8. MicroRNA12▲ 168×1 topic
  9. Targeting12▲ 294×1 topic
  10. Gene Therapy6▲ 37×4 topics
  11. RNA Interference6▲ 74×1 topic
  12. siRNA Delivery6▲ 111×1 topic
  13. Translation5▲ 34×2 topics
  14. Cancer Progression4▲ 26×4 topics
  15. Cellular Functions4▲ 75×2 topics
  16. Cancer Therapy4▲ 8.6×10 topics
  17. Nanoparticles3▲ 3.9×7 topics
  18. RNA methylation3▲ 61×1 topic
  19. m6A-seq3▲ 61×1 topic
  20. Circular RNAs3▲ 171×1 topic
  21. MicroRNA Sponges3▲ 171×1 topic
  22. Self-Assembly3▲ 10×2 topics
  23. Biosensors2▲ 5.7×3 topics
  24. Epigenetic Regulation2▲ 16×2 topics
  25. DNA nanotechnology2▲ 31×1 topic
  26. Immune Response2▲ 5.3×10 topics
  27. aptamers2▲ 31×1 topic
  28. Drug Delivery2▲ 6.1×6 topics
  29. Vaccine2▲ 7.0×6 topics
  30. Innate Immunity2▲ 7.8×5 topics
  31. Cell Death2▲ 12×2 topics
  32. Long Noncoding RNAs2▲ 39×1 topic
  33. RNA Regulation2▲ 22×1 topic
  34. Therapeutic Targets2▲ 10×5 topics
  35. BRCA Mutation2▲ 134×1 topic
  36. Homologous Recombination2▲ 35×2 topics
  37. Immunity2▲ 6.6×3 topics
  38. PARP Inhibitors2▲ 134×1 topic
  39. RNA Structure2▲ 23×1 topic
  40. Ribosome2▲ 23×1 topic

Which research topics does Mirna Therapeutics (United States) publish most on?

By volume in 2022–2025: PARP inhibition in cancer therapy, Advancements in Transdermal Drug Delivery, Cancer Treatment and Pharmacology and Advanced Drug Delivery Systems.

  1. 1 PARP inhibition in cancer therapy Oncology 2 works
  2. 2 Advancements in Transdermal Drug Delivery Pharmaceutical Science 1 works
  3. 3 Cancer Treatment and Pharmacology Oncology 0 works
  4. 4 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
  6. 6 Immunotherapy and Immune Responses Immunology 0 works
  7. 7 Virus-based gene therapy research Genetics 0 works
  8. 8 Education, Law, and Society Political Science and International Relations 0 works
  9. 9 Diverse Music Education Insights Music 0 works
  10. 10 Facial Nerve Paralysis Treatment and Research Neurology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available52.4%not open47.6%

World: 28% of research is openly available.

with international co-authors26.0%domestic only74.0%

World: 19% is written across borders.

How has Mirna Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 64% lower than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Austin

All research institutions in Austin

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.